These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19874330)

  • 1. Predictors of patient satisfaction with initial diagnosis and management of malignant melanoma.
    Sheth N; Sarker SJ; Harries M; Healy C; Russell-Jones R; Acland K
    Clin Exp Dermatol; 2010 Aug; 35(6):599-602. PubMed ID: 19874330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial benefits of sentinel lymph node biopsy in the management of cutaneous malignant melanoma.
    Rayatt SS; Hettiaratchy SP; Key A; Powell BW
    Br J Plast Surg; 2002 Mar; 55(2):95-9. PubMed ID: 11987939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma survivors at high risk of developing new primary disease: a qualitative examination of the factors that contribute to patient satisfaction with clinical care.
    McLoone JK; Watts KJ; Menzies SW; Barlow-Stewart K; Mann GJ; Kasparian NA
    Psychooncology; 2013 Sep; 22(9):1994-2000. PubMed ID: 23382138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Malignant melanoma of the skin].
    Simon JC; Grimme H; Bergen E; Vanscheidt W; Schöpf E
    Fortschr Med; 1995 Oct; 113(28):393-6. PubMed ID: 7498864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of melanoma on patients' lives among 562 survivors: a Dutch population-based study.
    Holterhues C; Cornish D; van de Poll-Franse LV; Krekels G; Koedijk F; Kuijpers D; Coebergh JW; Nijsten T
    Arch Dermatol; 2011 Feb; 147(2):177-85. PubMed ID: 21339445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of health care delivery models on melanoma thickness and stage in a university-based referral center: an observational pilot study.
    Swetter SM; Soon S; Harrington CR; Chen SC
    Arch Dermatol; 2007 Jan; 143(1):30-6. PubMed ID: 17224539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and psychosocial factors related to delay behavior in patients with cutaneous malignant melanoma.
    Temoshok L; DiClemente RJ; Sweet DM; Blois MS; Sagebiel RW
    Prog Clin Biol Res; 1984; 156():169-79. PubMed ID: 6473424
    [No Abstract]   [Full Text] [Related]  

  • 8. Melanoma of the head and neck: current concepts in diagnosis and management.
    Lentsch EJ; Myers JN
    Laryngoscope; 2001 Jul; 111(7):1209-22. PubMed ID: 11568543
    [No Abstract]   [Full Text] [Related]  

  • 9. Baseline psychosocial predictors of survival in localized melanoma.
    Lehto US; Ojanen M; Dyba T; Aromaa A; Kellokumpu-Lehtinen P
    J Psychosom Res; 2007 Jul; 63(1):9-15. PubMed ID: 17586333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Important first chance.
    Avery JK
    J Ark Med Soc; 2007 May; 103(11):269. PubMed ID: 17539456
    [No Abstract]   [Full Text] [Related]  

  • 11. [Regression of over 150 skin metastases of malignant melanoma with complex homeopathic therapy].
    Ehring F
    Hautarzt; 1989 Jan; 40(1):23-7. PubMed ID: 2921115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amelanotic malignant lentigo melanoma].
    Hofmann H; Lincke-Plewig H; Plewig G
    Hautarzt; 1986 May; 37(5):281-3. PubMed ID: 3733448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient satisfaction with receiving skin cancer diagnosis by letter: comparison with face-to-face consultation.
    Karri V; Bragg TW; Jones A; Soldin M; Misch K
    J Plast Reconstr Aesthet Surg; 2009 Aug; 62(8):1059-62. PubMed ID: 18485851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of malignant melanoma of the skin (a lecture)].
    Denisov LE; Kurdina MI
    Khirurgiia (Mosk); 1996; (1):17-22. PubMed ID: 8683912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' experience of the diagnosis and treatment of skin cancer.
    Winterbottom A; Harcourt D
    J Adv Nurs; 2004 Nov; 48(3):226-33. PubMed ID: 15488036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Initial evaluation, diagnosis, staging, treatment, and follow-up of patients with primary cutaneous malignant melanoma. Consensus statement of the Network of Catalan and Balearic Melanoma Centers].
    Mangas C; Paradelo C; Puig S; Gallardo F; Marcoval J; Azon A; Bartralot R; Bel S; Bigatà X; Curcó N; Dalmau J; del Pozo LJ; Ferrándiz C; Formigón M; González A; Just M; Llambrich A; Llistosella E; Malvehy J; Martí RM; Nogués ME; Pedragosa R; Rocamora V; Sàbat M; Salleras M
    Actas Dermosifiliogr; 2010 Mar; 101(2):129-42. PubMed ID: 20223155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant melanoma. Introduction].
    Banzet P
    Chirurgie; 1978 Nov; 104(10):946-7. PubMed ID: 747944
    [No Abstract]   [Full Text] [Related]  

  • 18. Symptoms and signs of primary melanoma: important indicators of Breslow depth.
    Negin BP; Riedel E; Oliveria SA; Berwick M; Coit DG; Brady MS
    Cancer; 2003 Jul; 98(2):344-8. PubMed ID: 12872355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant melanoma--a challenge for the physician].
    Seebacher C
    Z Arztl Fortbild (Jena); 1988; 82(9):401-4. PubMed ID: 3218266
    [No Abstract]   [Full Text] [Related]  

  • 20. Malignant melanoma: prognostic factors and therapeutic results.
    DeVita VT; Fisher RI
    W V Med J; 1977 Aug; 73(8):167-72. PubMed ID: 268079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.